Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

Urology

Volumn 46, Issue 2, 1995, Pages 187-194

  Luderer, Albert A ^a,b,c   Chen, Ya Ting ^a,b,c   Soriano, Thomas F ^a,b,c   Kramp, William J ^a,b,c   Carlson, Grant ^a,b,c   Cuny, Carol ^a,b,c   Sharp, Thomas ^a,b,c   Smith, William ^a,b,c   Petteway, Jason ^a,b,c   Brawer, Michael K ^a,b,c   Thiel, Robert ^a,b,c  

^a Dianon Systems   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c SOUTHERN CONNECTICUT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPARATIVE STUDY; DIAGNOSIS, DIFFERENTIAL; HUMAN; IMMUNOASSAY; MALE; MIDDLE AGE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIOIMMUNOASSAY; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0028828899     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80192-7     Document Type: Article

References (21)

1. Purification of a human prostate-specific antigen
2. Prostate-specific antigen as a marker for adenocarcinoma of the prostate
3. Enzymatic activity of the prostate-specific antigen and its reactions with extra-cellular serine proteinase inhibitors
4. 1-antichymotrypsin
5. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer:assay of the complex improves clinical sensitivity for cancer
6. The clinical usefulness of prostate specific antigen:update 1994
7. 1-antichymotrypsin as an indicator of prostate cancer
8. 1-antichymotrypsin complexes in serum
9. 1-antichymotrypsin
10. Influence of patient age on the serum PSA concentration. An important clinical observation
11. Evaluation of a two-site immunoradiometric assay for the measurement of non-complexed (free) PSA
12. Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions
13. Screening for prostatic carcinoma with prostate specific antigen
14. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
15. Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management
16. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease
17. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
18. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change
19. Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays
20. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves